By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

MediciNova, Inc. 

4350 La Jolla Village Drive, Suite 950

San Diego  California  92122  U.S.A.
Phone: 858-373-1500 Fax: 858-373-7000


SEARCH JOBS


Industry
Biotechnology






Company News
MediciNova, Inc. Announces New NIDA Grant For MN-166 (Ibudilast) In Opioid Dependence 9/8/2014 7:42:08 AM
MediciNova, Inc. To Present Data On MN-001 (Tipelukast) For The Treatment Of Idiopathic Pulmonary Fibrosis (IPF) During The 18th International Colloquium On Lung And Airway Fibrosis (ICLAF) 9/2/2014 7:55:20 AM
MediciNova, Inc. To Initiate Clinical Trial Of MN-166 (Ibudilast) In ALS 8/26/2014 7:16:24 AM
MediciNova, Inc. Shows Off Positive Phase 2a Study Of Ibudilast 8/19/2014 6:16:00 AM
MediciNova, Inc. Receives Notice Of Allowance For New Patent Covering MN-001 And MN-002 For The Treatment Of Nonalcoholic Fatty Liver Disease 8/11/2014 5:23:23 PM
MediciNova, Inc. Announces Positive Results Of MN-001 In Advanced NASH Mouse Model; Medicinova Requests A Meeting With FDA 8/5/2014 8:29:19 AM
MediciNova, Inc. To Present Data On MN-001 For The Treatment Of NASH (Nonalcoholic Steatohepatitis) During The JDDW 2014 (Japan Digestive Disease Week 2014) 7/8/2014 6:16:41 AM
MediciNova, Inc. Announces Positive Results In Study Of MN-001 In Mouse Model Of Pulmonary Fibrosis 6/12/2014 7:57:10 AM
MediciNova, Inc. Announces Management Appointment 4/9/2014 8:51:00 AM
MediciNova, Inc. Announces Positive Results In NASH Mouse Model With MN-001 And Prepares To Initiate Phase 2 Trial In The U.S. 1/14/2014 9:09:38 AM
12345678910...
//-->